PatentsUSA
Biotechnology company Moderna has agreed to pay up to $2.25 billion to settle patent litigation over technology used in its COVID-19 vaccine, resolving a dispute with Arbutus Biop…
Biotechnology company Moderna has agreed to pay up to $2.25 billion to settle patent litigation over technology used in its COVID-19 vaccine, resolving a dispute with Arbutus Biopharma and Genevant Sciences. The lawsuits alleged that Moderna’s vaccine relied on patented lipid nanoparticle delivery systems, a technolog…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
High Court Upholds Lanham Act Name Clause, Clarifies Copyright Damages, and Considers Scope of Profits in Trademark Disputes
The U.S. Supreme Court concluded its 2023-24 term with significant decisions impacting intellectual property law, including a unanimous ruling on the Lanham Act’s name clause and a split decision on the timing of copyright damages. As the 2024-25 term begins, the Court has agreed to hear additional IP cases while decl…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
A year of pivotal court decisions, evolving litigation venues, and increased focus on technology-driven IP cases reshapes the U.S. intellectual property landscape.
The year 2024 proved transformative for U.S. intellectual property litigation, marked by steady case volumes, landmark Supreme Court and Federal Circuit decisions, and a surge in disputes involving artificial intelligence and trade secrets. Shifts in venue dynamics, the end of Chevron Deference, and the growing influe…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
Actavis Laboratories FL, Inc. secures key tax victory as court rules patent defense expenses are immediately deductible business costs
In a landmark decision, the Federal Circuit has ruled that generic pharmaceutical companies may deduct legal expenses incurred in defending Hatch-Waxman patent litigation as ordinary and necessary business expenses. The ruling, which affirms a lower court's decision in favor of Actavis Laboratories FL, Inc., clarifies…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
Actavis Laboratories secures key tax ruling affirming deductibility of Hatch-Waxman patent litigation expenses tied to ANDA filings
The U.S. Court of Appeals for the Federal Circuit has affirmed that generic drug manufacturers may immediately deduct patent litigation expenses incurred in connection with Abbreviated New Drug Application (ANDA) filings under the Hatch-Waxman Act. The decision, favoring Actavis Laboratories, clarifies that such litig…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
Western and Eastern Districts of Texas Remain Central to U.S. Patent Disputes Despite Changes in Case Assignment Procedures
Patent litigation in Texas experienced notable changes in 2022 following a judicial order that altered case assignment in the Western District. While filings in the Western District of Texas (WDTX) declined after the order, the drop was less severe than anticipated, and Judge Alan Albright continued to preside over a…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
Federal partnership aims to expand intellectual property education and innovation support across eight-state region
The University of Utah has entered into a formal agreement with the U.S. Patent and Trademark Office to host a new Mountain West Community Engagement Office. This initiative, part of the Unleashing American Innovators Act of 2022, is designed to provide intellectual property education, resources, and outreach to stude…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsGlobal
Mintz's intellectual property team earns distinction in IAM's annual guide, highlighting strategic expertise across multiple sectors.
Eleven attorneys from Mintz have been selected for the 2026 edition of the IAM Strategy 300 Global Leaders Guide, underscoring the firm's reputation for strategic intellectual property counsel. The recognition reflects Mintz's broad capabilities in patent litigation, monetization, and IP transactions, serving a divers…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
Jury finds Yealink liable for patent infringement but rejects claims of willful misconduct and inducement; Yealink pursues further challenges to Barco’s US patents.
Barco has been awarded just over $907,000 in damages by a jury in the Eastern District of Texas after prevailing in a patent infringement case against Yealink concerning its ClickShare technology. The jury found Yealink liable for infringing six Barco patents through the sale of its WPP20 and WPP30 wireless presentati…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsEurope
“Litigation in Europe continues to be marked by strategic jurisdictional battles and choices…. Recent decisions in both the UK and CJEU show favorabl…
“Litigation in Europe continues to be marked by strategic jurisdictional battles and choices…. Recent decisions in both the UK and CJEU show favorable outcomes for rights owners.”
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
Section 337 complaint targets major crystalline silicon panel makers, seeking broad exclusion of infringing TOPCon solar cells from U.S. market
First Solar has filed a Section 337 complaint with the U.S. International Trade Commission, alleging that ten leading solar panel manufacturers have infringed its patent covering tunnel oxide passivated contact (TOPCon) technology. The company seeks a general exclusion order to block imports of any TOPCon solar cells…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsGlobal
Engagement with Am Law 200 firm aims to secure IP, streamline technology transfer, and accelerate commercialization of electro-optic polymer platform
Lightwave Logic, Inc. has engaged Michael Best & Friedrich LLP as outside counsel to lead its intellectual property strategy, focusing on invention harvesting, patent prosecution, international filings, portfolio management, and licensing. The collaboration is designed to protect Lightwave Logic’s proprietary electro-…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsGlobal
Engagement aims to fortify IP protection and streamline licensing as Lightwave Logic advances commercialization of electro-optic polymer technology.
Lightwave Logic, Inc. has engaged Michael Best & Friedrich LLP as its strategic intellectual property advisor, seeking to bolster protection of its proprietary electro-optic polymer platform and facilitate a licensing-driven revenue model. The collaboration will focus on invention harvesting, patent prosecution, inter…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUK
IP law firm expands UK presence with move into Birmingham’s tallest office building
Withers & Rogers, a leading intellectual property law firm, has announced the opening of a new office in Birmingham, marking a significant expansion of its UK operations. The firm’s new base will be located in the tallest office space in the city, reinforcing its commitment to growth in the region.
Wednesday, April 29, 2026
IIPLA News Desk
PatentsUSA
The Tennessee-based EBOS company is hoping the second time is the charm in its efforts to stop Voltage, LLC from selling its trunk bus products in th…
The Tennessee-based EBOS company is hoping the second time is the charm in its efforts to stop Voltage, LLC from selling its trunk bus products in the U.S.
Wednesday, April 29, 2026
IIPLA News Desk
PatentsEurope
Efforts by Ukraine’s Bureau of Economic Security to tax vehicle leasing as royalties spark legal debate and industry concerns
Ukrainian legal professionals are raising alarms over the Bureau of Economic Security’s attempts to classify leasing payments for vehicles, including aircraft, as royalties subject to additional taxation. Experts argue that such payments do not involve the transfer of intellectual property rights and warn that the mov…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsGlobal
Court finds no infringement of Emboline’s embolic protection device patent, emphasizing the significance of normal professional use in medical device claims.
The Munich Local Division of the Unified Patent Court has ruled in favor of AorticLab srl, finding no infringement of Emboline Inc.'s patent for an embolic protection device. The decision underscores the importance of interpreting claim features in light of normal professional use, particularly for medical devices. Th…
Wednesday, April 29, 2026
IIPLA News Desk
PatentsEurope
Court affirms intra-procedural condition on revocation counterclaim, but finds no infringement and orders defendant to pay related costs
The Munich Local Division of the Unified Patent Court has ruled that a defendant may condition a counterclaim for revocation on a finding of infringement, provided it does not disadvantage the claimant. In the case between Emboline Inc. and AorticLab srl, the court ultimately found no infringement, rendering the count…
Wednesday, April 29, 2026
IIPLA News Desk
